These findings demonstrate that autophagy elicited by anti-EGFR–GNs-combined NIR-PTT is an alternative cell death mechanism, resulting in most effective cancer therapy for EGFR-targeted TNBC [134]. This evidence concerns the gene EGFR and cancer.